Alnylam Pharmaceuticals Inc (ALNY)

(10% Negative) Alnylam Pharmaceuticals, Inc. (ALNY) Announces Delay in amyloidosis Trials for adults Due to Pandemic-Related Challenges, Regulatory Process, Safety Review, Efficacy Assessment

Iovance Biotherapeutics Inc (IOVA)

(75% Positive) IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Announces Enrollment Update for needs Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment